FDA NDC Directory · JSON-LD · Markdown

Boncresa

NDC 70121-2702 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namedenosumab-mobz
Labeler / ManufacturerAmneal Pharmaceuticals LLC
Marketing categoryBiologic License Application · App BLA761456
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsDENOSUMAB (60 mg/mL)
Marketing started20251223
Package count1

External sources

Source: openFDA. Public-domain (CC0).